SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-22-001091
Filing Date
2022-04-13
Accepted
2022-04-13 09:00:48
Documents
17
Period of Report
2022-04-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gern4048171-8k.htm   iXBRL 8-K 31636
2 21ST ANNUAL NEEDHAM VIRTUAL HEALTHCARE gern4048171-ex991.htm EX-99.1 984
6 GRAPHIC gern4048171-ex991x1x1.jpg GRAPHIC 1972628
7 GRAPHIC gern4048171-ex991x2x1.jpg GRAPHIC 4339112
8 GRAPHIC gern4048171-ex991x3x1.jpg GRAPHIC 1898063
9 GRAPHIC gern4048171-ex991x4x1.jpg GRAPHIC 1854034
  Complete submission text file 0001206774-22-001091.txt   14065622

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20220413.xsd EX-101.SCH 2950
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220413_pre.xml EX-101.PRE 22353
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220413_lab.xml EX-101.LAB 34240
11 EXTRACTED XBRL INSTANCE DOCUMENT gern4048171-8k_htm.xml XML 3595
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 22823768
SIC: 2834 Pharmaceutical Preparations